Aviation Medication Transparency Act of 2024

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9243 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 9243

To require the Administrator of the Federal Aviation Administration to 
publish the list of medications that the Administrator has compiled for 
    purposes of the medical certification of airmen, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             August 2, 2024

 Mr. Casten (for himself and Mr. Yakym) introduced the following bill; 
       which was referred to the Committee on Transportation and 
                             Infrastructure

_______________________________________________________________________

                                 A BILL


 
To require the Administrator of the Federal Aviation Administration to 
publish the list of medications that the Administrator has compiled for 
    purposes of the medical certification of airmen, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Aviation Medication Transparency Act 
of 2024''.

SEC. 2. LIST OF APPROVED MEDICATIONS.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Administrator of the Federal Aviation Administration 
shall publish and maintain on a publicly available website of the 
Administration the list of medications that may be safely prescribed to 
an airman to treat certain medical conditions that the Administrator 
has compiled for purposes of the issuance of a medical certification to 
an airman.
    (b) Requirements.--The list required under subsection (a) shall--
            (1) be drafted in consultation with--
                    (A) the Aeromedical Innovation and Modernization 
                Working Group;
                    (B) pilots and air traffic controllers; and
                    (C) any other stakeholder the Administrator 
                determines appropriate;
            (2) be comprehensive;
            (3) be drafted in a user-friendly and accessible manner and 
        distributed widely to airmen at the time when such airmen first 
        seek a license and medical certification;
            (4) indicate what, if any, period of time, on average, an 
        airman must have limited or no duties to stabilize on a 
        medication;
            (5) include the list of medications that the Administrator 
        has designated as ``Do Not Issue''; and
            (6) include any other information or clarification that the 
        Administrator determines appropriate.
    (c) Annual Update.--Not later than 1 year after the date of 
publication of the list required under subsection (a), and annually 
thereafter, the Administrator shall update such list, as appropriate.
                                 <all>